Results 241 to 250 of about 347,568 (271)
Some of the next articles are maybe not open access.
2013
Juvenile dermatomyositis (JDM) is a systemic, inflammatory, idiopathic disease, mainly affecting the skin and the muscles, starting before the age of 16, with an incidence around one case per 1 million children. Some patients display typical features of JDM without skin involvement, or even without muscle involvement; however, both tissues are affected
Pierre, Quartier, Romain K, Gherardi
openaire +3 more sources
Juvenile dermatomyositis (JDM) is a systemic, inflammatory, idiopathic disease, mainly affecting the skin and the muscles, starting before the age of 16, with an incidence around one case per 1 million children. Some patients display typical features of JDM without skin involvement, or even without muscle involvement; however, both tissues are affected
Pierre, Quartier, Romain K, Gherardi
openaire +3 more sources
Zeitschrift für Rheumatologie, 2006
Juvenile dermatomyositis (JDM) is an inflammatory multi-system disease of unknown etiology with classic involvement of the skin and striated muscles. Following a prodromal period, patients develop a progressive proximal muscle weakness. Typical skin involvement includes heliotrope rash, facial erythema, Gottron's sign and nailfold capillary ...
F, Dressler, H-I, Huppertz
openaire +2 more sources
Juvenile dermatomyositis (JDM) is an inflammatory multi-system disease of unknown etiology with classic involvement of the skin and striated muscles. Following a prodromal period, patients develop a progressive proximal muscle weakness. Typical skin involvement includes heliotrope rash, facial erythema, Gottron's sign and nailfold capillary ...
F, Dressler, H-I, Huppertz
openaire +2 more sources
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 2018
Clinical History: A 2 year old female presented with fever and petechial rash over both lower limbs for 1 month. She developed facial puffiness and pedal edema. She further complained of lower limb pain and weakness for 5 days.
Sarah, Keller +2 more
openaire +3 more sources
Clinical History: A 2 year old female presented with fever and petechial rash over both lower limbs for 1 month. She developed facial puffiness and pedal edema. She further complained of lower limb pain and weakness for 5 days.
Sarah, Keller +2 more
openaire +3 more sources
Juvenile Dermatomyositis: Advances in Pathogenesis, Assessment, and Management.
Current pediatric reviews, 2021BACKGROUND Juvenile dermatomyositis is the most common inflammatory myopathy in the pediatric age group and a major cause of mortality and morbidity in individuals with childhood rheumatic diseases.
A. Leung +4 more
semanticscholar +1 more source
Autologous CD19‐Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis
Arthritis & RheumatologyThe aim of this study is to report the safety and efficacy of CD19‐targeting chimeric antigen receptor (CAR) T cells in a child with refractory juvenile dermatomyositis (JDM).
R. Nicolai +15 more
semanticscholar +1 more source
International Journal of Rheumatic Diseases, 2021
Tofacitinib has an important role in pediatric rapidly progressive interstitial lung disease (ILD) associated with juvenile dermatomyositis (JDM), an otherwise potentially fatal condition. It may be useful in induction of remission and can be used safely
Poh Lin Pauline Chan Ng +7 more
semanticscholar +1 more source
Tofacitinib has an important role in pediatric rapidly progressive interstitial lung disease (ILD) associated with juvenile dermatomyositis (JDM), an otherwise potentially fatal condition. It may be useful in induction of remission and can be used safely
Poh Lin Pauline Chan Ng +7 more
semanticscholar +1 more source
Rheumatic Disease Clinics of North America, 1991
Juvenile dermatomyositis is a relatively rare, multisystem disease characterized by a nonsuppurative myositis which causes symmetrical weakness, rash and vasculitis; this last can affect the gastrointestinal tract and the myocardium. Late development of calcinosis is seen in approximately two thirds of patients.
openaire +3 more sources
Juvenile dermatomyositis is a relatively rare, multisystem disease characterized by a nonsuppurative myositis which causes symmetrical weakness, rash and vasculitis; this last can affect the gastrointestinal tract and the myocardium. Late development of calcinosis is seen in approximately two thirds of patients.
openaire +3 more sources
Rheumatology, 2022
OBJECTIVE To evaluate the use of Janus kinase inhibitor (JAKi) in treating JDM and develop cytokine biomarkers of active disease. METHODS This study involved a retrospective cohort study that evaluated JAKi in 101 JDM patients as well as a cross ...
Baozhen Huang +11 more
semanticscholar +1 more source
OBJECTIVE To evaluate the use of Janus kinase inhibitor (JAKi) in treating JDM and develop cytokine biomarkers of active disease. METHODS This study involved a retrospective cohort study that evaluated JAKi in 101 JDM patients as well as a cross ...
Baozhen Huang +11 more
semanticscholar +1 more source
Juvenile amyopathic dermatomyositis
British Journal of Dermatology, 1997We report a 15-year-old girl with a 10-year-old history of typical skin features of dermatomyositis (DM) without evidence of muscle involvement. Amyopathic dermatomyositis (ADM) is defined by the presence of biopsy confirmed classic cutaneous findings of dermatomyositis in the absence of any clinical or laboratory signs of muscle disease for at least 2
M H, Schmid, R M, Trüeb
openaire +2 more sources
International Journal of Rheumatic Diseases, 2021
Patients with juvenile dermatomyositis (JDM) experience muscle weakness, tiredness, and loss of energy, which restrict their abilities in performance of their daily living activities.
R. Elnaggar, Walaa A. Abd El-Nabie
semanticscholar +1 more source
Patients with juvenile dermatomyositis (JDM) experience muscle weakness, tiredness, and loss of energy, which restrict their abilities in performance of their daily living activities.
R. Elnaggar, Walaa A. Abd El-Nabie
semanticscholar +1 more source